2-氨基乙基苯砜盐酸盐 | 38752-48-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基乙基苯砜盐酸盐
• 中文别名: 2-[(苯甲砜基)-乙胺盐酸盐
• 英文名称: 2-benzenesulfonyl-ethylamine Hydrochloride
• 英文别名: 2-aminoethyl phenyl sulfone hydrochloride；2-(Phenylsulfonyl)ethanamine hydrochloride；2-benzenesulfonyl-ethylamine; hydrochloride；2-Benzolsulfonyl-aethylamin; Hydrochlorid；2-(phenylsulfonyl)-ethylamine hydrochloride；Phenyl-2-aminoethylsulfon-hydrochlorid；2-(benzenesulfonyl)ethanamine;hydrochloride
• CAS: 38752-48-6
• 化学式: C₈H₁₁NO₂S*ClH
• mdl: MFCD03840163
• 分子量: 221.708
• InChiKey: HSFNBRHAUKLROY-UHFFFAOYSA-N

物化性质

• 熔点：
  155-155.5 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.17
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  68.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2921499090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(Benzenesulfonyl)ethan-1-amine, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(Benzenesulfonyl)ethan-1-amine, HCl
CAS number: 38752-48-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11NO2S.ClH
Molecular weight: 221.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基乙基苯砜盐酸盐 在 氢溴酸 作用下， 以 溶剂黄146 为溶剂， 生成 2-Amino-N-(2-benzenesulfonyl-ethyl)-acetamide
  参考文献：
  名称：

  合成δ-氨基松油酸类似物作为潜在的抗疟药

  摘要：

  作为潜在抗疟药合成研究的一部分，制备了许多δ-氨基乳油酸（5-氨基-4-氧戊酸）类似物：（1）5-（吗啉代-，哌啶子基-或N-（2）1-氨基-4-（苯基或对氯苯基）磺酰基丁烷-2-一盐酸盐，（3）1-（苯甲酰基或烟酰基-）2-甘氨酰氢溴酸盐， （4）1 -甘氨酰- 2-（p甲苯基-或p -氯苯基- ） -氢溴酸sulphonylhydrazine，（5）甘氨酸phenacyl-或p -bromophenacyl -酰胺氢溴酸盐，（6）甘氨酸2-（苯基-或p -甲苯基-）磺酰基乙基酰胺氢溴酸盐和（7）1-乙氧基羰基-2-甘氨酰肼盐酸盐。

  DOI：

  10.1039/j39680001399
• 作为产物：
  描述：

  2-氯乙基苯基砜 在 ammonium hydroxide 作用下， 以 甲醇 为溶剂， 160.0 ℃ 、2.41 MPa 条件下， 反应 0.17h， 以81%的产率得到2-氨基乙基苯砜盐酸盐
  参考文献：
  名称：

  连续流动中由氢氧化铵和羟胺化学选择性合成胺的方法

  摘要：

  连续流动实现烷基溴和氯化物与氨水和羟胺的化学选择性胺化，以高收率生产伯铵盐和羟胺。设计了在线后处理以分离相应的伯胺，该伯胺也可通过进一步反应进行缩合，例如酰化和Paal-Knorr吡咯合成。单取代的环氧化物也与反应条件相容。

  DOI：

  10.1021/acs.joc.8b02387

文献信息

• INHIBITORS OF PRENYL-PROTEIN TRANSFERASE
  申请人：——

  公开号：US20020045759A1

  公开（公告）日：2002-04-18

  The present invention is directed to peptidomimetic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.

  本发明涉及抑制异戊二烯蛋白转移酶和癌基因蛋白Ras的预尾基类似物化合物。该发明进一步涉及含有本发明化合物的化疗组合物以及用于抑制异戊二烯蛋白转移酶和癌基因蛋白Ras的预尾基化的方法。
• Anilinoquinazaolines as protein tyrosine kianse inhibitors
  申请人：Cockerill Stuart George

  公开号：US20050143401A1

  公开（公告）日：2005-06-30

  Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.

  本发明描述了杂环芳香化合物，它们的制备方法，含有它们的药物组合物，使用方法以及它们在药物中的应用。特别是，本发明涉及表现出蛋白酪氨酸激酶抑制活性的喹唑啉和吡啶嘧啶衍生物。
• [EN] PYRIDOPYRIMIDINES AS HISTAMINE H4-RECEPTOR INHIBITORS<br/>[FR] PYRIDOPYRIMIDINES EN TANT QU'INHIBITEURS DU RÉCEPTEUR H4 DE L'HISTAMINE
  申请人：FAES FARMA SA

  公开号：WO2020020939A1

  公开（公告）日：2020-01-30

  The invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor.

  该发明涉及式(I)的化合物或其药用可接受的盐或溶剂，以及包含它们的药物组合物，以及它们在治疗和/或预防由组胺H4受体介导的疾病或疾病中的用途。
• .beta.-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols
  作者：H. Tucker、J. F. Coope

  DOI：10.1021/jm00206a010

  日期：1978.8

  The synthesis is described of a seris of derivaties of 1-(aryloxy)-3-(arylthioalkylamiho)propan-2-ols and 1-(alkylthioamino)- and 1-(aralkylamino)-3-(aryloxy)propan-2-ols. These compounds were investigated for their beta-adrenoreceptor blocking properties and their selectivity of action for the cardiac beta1 receptor. The structure-activity relationships are discussed with particular reference to the

  描述了1-（芳氧基）-3-（芳硫基烷基氨基）丙烷-2-醇和1-（烷基硫氨基）-和1-（芳烷基氨基）-3-（芳氧基）丙烷-2-醇的衍生物系列的合成。研究了这些化合物的β-肾上腺素受体阻滞特性以及对心脏β1受体的选择性作用。特别参考硫，亚砜和砜基团对β-肾上腺素受体阻断效能和选择性的影响，讨论了结构活性关系。
• N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of
  申请人：A. H. Robins Company, Incorporated

  公开号：US04724235A1

  公开（公告）日：1988-02-09

  N-(Arylthioalkyl)-N'-(aminoalkyl)ureas and thioureas and oxidation derivatives having the formula ##STR1## wherein B is thio, sulfinyl or sulfonyl; R.sup.1 and R.sup.2 are hydrogen, loweralkyl, cycloalkyl, 2-furanyl, phenyl, substituted phenyl or phenyl-loweralkyl and R.sup.3 and R.sup.4 are hydrogen, loweralkyl, phenyl or phenyl-loweralkyl wherein phenyl is optionally substituted, or R.sup.3 and R.sup.4 taken with the adjacent nitrogen form a heterocyclic residue. The compounds are useful in the treatment of cardiac arrhythmia.

  N-(芳基硫代烷基)-N'-(氨基烷基)脲和硫脲以及具有公式##STR1##的氧化衍生物，其中B是硫、亚砜基或磺酰基；R1和R2是氢、较低烷基、环烷基、2-呋喃基、苯基、取代苯基或苯基-较低烷基，R3和R4是氢、较低烷基、苯基或苯基-较低烷基，其中苯基可选择性地被取代，或R3和R4与相邻的氮形成杂环残基。这些化合物在治疗心律失常方面有用。